1 2 3 4
News & Information
Daddy’s Boys – a new play tackling prostate cancer disparity in African-American men Daddy’s Boys – a new play tackling prostate cancer disparity in African-American men

Astellas Pharma highlights PHEN's "infotainment" initiative in its Change Together online portal
Prostate Cancer: ADT Plus Docetaxel May Improve 12-Month Quality of Life

Androgen-deprivation therapy (ADT) with docetaxel may improve quality of life (QoL) at 12 months among patients with metastatic hormone-sensitive prostate cancer

Xtandi Reduces Risk of Metastasis in Castration-resistant Prostate Cancer

Treatment with Xtandi (enzalutamide) reduced the risk of metastasis or death in castration-resistant prostate cancer (CRPC) patients whose cancer has not yet spread beyond the prostate.

Patients should Patients should "Ask-In" on clinical trials participation

African American participation in prostate cancer clinical trials must move from 3-5% range to 10-12% range to determine the effectiveness of new treatments.

Two new treatments have been found for prostate cancer patients who previously had no effective treatment options

Clinical trials have found that Enzalutamide and Apalutamide are both able to significantly delay prostate cancer progression in men with non-metastatic castration-resistant prostate cancer. 
Survivor Network Spotlight - Raymond Fuller, Jr.

During a regular check-up in 2008, Ray Fuller was diagnosed with prostate cancer.  There was no family history of the disease, he said, it “just popped up.”

How dietary fat helps prostate cancer to spread

New research demonstrates how the fat contained within the Western diet, in combination with genetic factors, can cause prostate cancer tumors to spread.

Partners